In Silico Screening, Synthesis and In Vitro Evaluation of Some Quinazolinone and Pyridine Derivatives as Dihydrofolate Reductase Inhibitors for Anticancer Activity
Dihydrofolate reductase (DHFR) is the important target for anticancer drugs belonging to the class of antimetabolites as the enzyme plays important role in the de novo purine synthesis. We here report the in silico screening to obtain best fit molecules as DHFR inhibitors, synthesis of some ʻbest fi...
Saved in:
Main Authors: | A. G. Nerkar, A. K. Saxena, S. A. Ghone, A. K. Thaker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | E-Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2009/506576 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An In Silico Study of the Interactions of Alkaloids from Cryptolepis sanguinolenta with Plasmodium falciparum Dihydrofolate Reductase and Dihydroorotate Dehydrogenase
by: Lois Kwane Kyei, et al.
Published: (2022-01-01) -
Inhibitors of Human Dihydrofolate Reductase: A Computational Design and Docking Studies Using Glide
by: Lingala Yamini, et al.
Published: (2008-01-01) -
Synthesis, biological evaluations, and in silico assessments of phenylamino quinazolinones as tyrosinase inhibitors
by: Sara Moghadam Farid, et al.
Published: (2025-01-01) -
Resistance of <i>Wolbachia</i> to Trimethoprim: Insights into Genes Encoding Dihydrofolate Reductase, Thymidylate Synthase and Serine Hydroxymethyltransferase in the Rickettsiales
by: Ann M. Fallon
Published: (2024-12-01) -
Synthesis and Antimicrobial Activity of Newer Quinazolinones
by: J. A. Patel, et al.
Published: (2006-01-01)